TIS tissue therapies limited

potential +, page-2

  1. 120 Posts.
    TDA ,good work...

    all indications are we should easily capture 50%+ of the mrkt. with revenue closer to the 13-15% mark.

    Both parties are currently driving a hard bargain , Steve Mercer is not going to give the product away hence the delay, once all is revealed we can put some numbers together.

    I think we will easily achieve a billion worth of sales , which should give us revenue around the 150mill. mark,
    putting us on a mrkt. cap of close to 1.4billion or a share price of $7.44 and i am being conservative

    In contrast look at her current mrkt. cap.even if we achieve half of this , it still is one of the best short term growth stocks i know of on the ASX , another 3 months and all shall be revealed , we have held long enough, now need TIS to reward her holders

    cheers
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.